Business Development

Business Development

The Solution to Oral Peptide Delivery
Unigene’s industry leading Oral Peptide Delivery Platform

• Most Clinically Advanced
• Positive Phase 3 Oral Calcitonin
• Positive Phase 2 Oral Parathyroid Hormon
• Low Cost, Fast Turnaround Feasibility Studies
• Two Species
• Rodent
• Canine
• Standard 90 day turnaround
• Unigene’s Oral Peptide Delivery Offers
• Patient convenience over an injectable
• Increased commercial viability for early phase peptide
• Greater market potential for many peptides
• Lifecycle management
• Patent protection to 2028

For information on how Unigene can orally deliver your peptide please contact:
Business Development
businessdevelopment@unigene.com

Feasibility Pipeline